InvestorsHub Logo
Followers 37
Posts 2958
Boards Moderated 0
Alias Born 01/14/2003

Re: None

Saturday, 05/23/2020 10:43:33 AM

Saturday, May 23, 2020 10:43:33 AM

Post# of 423977
Chloroquine or hydroxychloroquine (HCQ), with or without an antibiotic, in hospitalized COVID-19 patients were associated with increased risk of death in the hospital and higher rates of arrhythmias, analysis of outcomes in nearly 100,000 patients indicated.

The 15,000 patients who received HCQ or chloroquine were about twice as likely to die compared to controls who did not receive these agents after adjusting for covariates (18.o% for hydroxychloroquine and 16% for chloroquine versus 9.3% for controls), reported Mandeep Mehra, MD, of Brigham and Women's Hospital in Boston, and colleagues.

https://www.medpagetoday.com/infectiousdisease/covid19/86642?xid=nl_mpt_DHE_2020-05-23&eun=g207787d0r


Com'on Vascepa,, you can do it!

It's the ratio, baby ... the EPA/AA ratio!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News